Try Mental Wellness – Lifestyle
Author:
Genmab A/S
Genmab Announces Financial Results for the First Quarter of 2026
May 7, 2026
Major Shareholder Announcement
April 14, 2026
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026
April 14, 2026
Major Shareholder Announcement
April 1, 2026
Major Shareholder Announcement
March 30, 2026